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Ageing is deﬁned as a slow, irreversible process of cellular changes, that are due to a lack of balance between degradation and
repair, a continuous interaction between physiological and pathological processes. Physiological aspects in elderly people are
often confused with disease. Given these general considerations, we would make observations about the dynamics of cortisol
secretion in healthy elderly subjects and patients with a diagnosed cardiovascular disease, more precisely hypertension. The study
was conducted during 2003–2010, on a number of 135 patients older than 65 years of age, who were divided into two groups: one
groupcounting66patientsandconsistingofhealthyelderlycontrols(withoutsystemicdisease,renal,endocrine,orcardiovascular
known issues) and group 2 who consists of 69 elderly patients who associate known hypertensive and other cardiovascular issues.
1.Introduction
Ageing is a worldwide recognized fact, implying social and
economic aspects, wich lay in the way ageing is controled,
because it could have an enormous impact regarding health-
care, hospitalization, and/or reconstructive surgery costs.
Ageing is a degrading, progressive, inward-oriented, uni-
versal process, and the threshold between physiological and
pathological is very thin [1]. Although the general approach
towards elderly patients is to increase the quality of life (free
prescriptions, occupational therapy, medical healthcare at
home), there are a lot of real and recognized situations when
the ageing phenomenon may lead to discrimination that can
range from providing poor medical healthcare to restricted
accessibility to some healthcare programs (e.g., screening
for breast cancer in women over 65). However, we must be
aware that the ageing process is in steady growth in all de-
veloped countries for two main reasons: on the one hand
due to reduced mortality and on the other due to decreasing
tendency of birth rate and fertility.
Aging is deﬁned as being a slow, irreversible changing
process that occurs within single cells—the seat of some
remarkable biochemical activity, whose development is
genetically programmed in advance [2]. The notion of time
in biology equals a measurement of motion in the form of
rhythms and cycles, of which the circadian biorhythms of
the endocrine functions are the most important. Variations
in normal hormonal secretions diﬀer from one hormone
to another in the course of 24 hours, so ACTH and cortisol
levels reach their peaks during early morning [3]. One of
the most well-spread theories regarding aging is based on
neuroendocrinology [4], and it well suits the global concept
stating the lack of balance between degradation and repair,
balance inﬂuenced by many internal and external factors [5].
Circadianrhythmofcortisolsecretionisstable,withlittle
inﬂuence from light and sleep, and it is also highly repro-
ductibile. It “matures” around the age of 4, remaining un-
changed into elder years, with no diﬀerence in the two sexes.
The rhythm of cortisol secretion is dependent on the circa-
dian secretion of ACTH, its acrophase being around 4 AM.2 International Journal of Hypertension
Feedback on the hypothalamic-pituitary axis, is exerted by
cortisolontheautonomouscircadianrhythm[6].Hormones
are secreted periodically, in a pulsatory manner. Hormonal
secretion ﬂuctuations may vary compared to time of day,
month, or year. The rhythm is deﬁned by a peak between
the hours of 6–8 AM, the lowest value being recorded in
the evening [7]. If more determinations of hormone levels
are analysed, an ultradian rhythm is revealed, with a daily
pulsatile secretion which reﬂects the episodic secretion of
the zona fasciculata, in four phases over night : before bed,
low cortisol secretion; during sleep, between 3–5 AM, higher
secretion levels; from the last hours of sleep and the ﬁrst
hour after awakening, maximum discharge; during activity
periods, intermittent discharge [8]. Clinical and paraclinical
evaluation of the degree of impaired hormonal secretions
in diseases—general and endocrine disorders—open new
perspectivesthatwilloptimizechronomodulatedtherapeutic
methods and means in relation to biological rhythms [9].
Starting from these general considerations, we wanted to
make some observations on the dynamics of cortisol secre-
tion in healthy elderly people and those with known car-
diovascular disease, especially those with hypertension.
2. Methods
The study was conducted in two locations: the Municipal
ClinicalHospital“Philanthropy”andtheEmergencyClinical
County Hospital in Craiova during 2003–2010, with both
a prospective and a retrospective component. Case studies
presented are based on a number of 135 patients, over 65
years of age, who were divided into two groups: group one
(SUBSET 1) consisting of 66 healthy elderly people (control
group),withoutsystemic,renal,endocrine,orcardiovascular
known issues at the time of enrollment in the group and
group 2 (SUBSET 2) consisting of 69 elderly patients who
associate diagnosed hypertensive disease and other cardio-
vascular issues (ischemic heart disease, degenerative valvular
heart disease, or arrhythmias, all of the patients being in
compensated stages of heart failure—grade I or II NYHA,
without any endocrine disorders). Of these, only 41 patients
can be considered as “true” hypertensive patients, because
the hypertension was the dominant issue compared to the
others associated problems.
Thecaseswereinvestigatedbymeansofclinicalexamina-
tion and cardiovascular evaluation carried out on standard
protocol, supplemented by laboratory tests and further
investigation (hematological, biochemical, enzymatic, hor-
monal, immunological, and imaging tests). Blood pressure
measurement was made under the same circumstances in all
subjects in the morning and evening, in supine and standing
positions. Blood pressure was also measured in both arms
due to the presence of atherosclerotic lesions, which in the
elderly patients can lead to variations in the levels of the
bloodpressurevalues.Measurementswererecordedforthree
consecutive days, and each individual patient’s values was
averaged to determine systolic and diastolic blood pressure.
TheWHOcriteriafordeﬁninghypertensionwerecommonly
used. We considered as signiﬁcant for the inclusion in
the category of hypertensive patients, values higher than
140mmHg (regarding systolic pressure), and also values
higher than 80mmHg (regarding the diastolic values). In
ordertobeabletocorrectlyclassifyhypertension,inaddition
to blood pressure measurement values, we aimed to assess
whether or not target organ damage could be recorded, optic
blood vessels were analysed, ECG and echocardiography (for
l e f tv e n t r i c u l a rh y p e r t r o p h y )w e r ep e r f o r m e d ,a sw e l la su r i -
nary protein dosage.
Patients in both groups were put through further hema-
tological and biochemical sorting investigations, along with
serum cortisol determination. The dosage system “Elecys
1010” found in the laboratory of the Emergency Clinical
County Hospital of Craiova was used to measure cortisol
levels. The sorting and assessment of trial groups were
completed by speciﬁc-cardiovascular oriented investigations
(echocardiography and electrocardiogram) and the complex
imaging explorations (radiology, ultrasound, and MRI).
The results were processed by statistical methods (Stu-
dent’s t-test, Bartlett’s test, Kruskal-Wallis’ test, Chi-squared
test, the arithmetic mean, standard deviation, ANOVA test,
and simple linear regression), using the “Data Analysis” sub-
package module Microsoft Excel program and also the
“EP12000” program, specialized in the execution of graphs,
tables, and statistical tests.
In this study, we will use data from the measurements of
cortisol levels, with normal values admitted to this study for
cortisol serum levels in the morning (measured between 7–
10 AM) ranging between 171 and 536nmol/L (cortisol 1),
while cortisol values in the evening (measured between the
hoursof6–8PM)rangebetween64and327nmol/L(cortisol
2).
3. Results
In this study, we analyzed two groups of patients in order
to observe the dynamics of hormonal secretion in elderly pa-
tients:acontrolgroup(subset1)consistingof66healthyeld-
erly people and a study group (subset 2) consisting of 69
elderly patients diagnosed with hypertensive disease associ-
ated with various cardiovascular diseases. The percentage
analysis of cases grouped by age showed that the largest
share of older people in both groups belonged to age group
of 75–84 years. The average values of biochemical and
hematological parameters were within normal limits of age
in both groups, except for some values of glucose or lipid
fractions.
Subset 1 or the control group was represented by healthy
elderly, who had been submitted for routine clinical and lab-
oratory tests. Following the recollection of past medical his-
tory, anamnesis, clinical examination, and laboratory tests,
66 healthy elderly people have been selected for the study.
The subset was composed of people over 65 years of age
(limits between 65 and 92 years), mean age being 78.31 in
men and 78.53 in women. Three age groups have been made:
ﬁrst age group ranging between 65 and 74, second one
ranging from 75 to 84, and the last group for patients older
than 84. The group’s structure included more men (40 male
cases) than women (26 cases), sex ratio equaling 1.53 in the
studied group.International Journal of Hypertension 3
Cortisol 1 values were measured in the morning, be-
tween 7 and 8 AM. Mean cortisol measured at this time
among the cases in SUBSET 1 was 336.92nmol/L (limits
at 172–537nmol/L, CI95% 306.47–367.38nmol/L). A sta-
tistically signiﬁcant diﬀerence between mean values of
cortisol 1 was not recorded in subjects from subset 1 re-
garding age diﬀerences (P = 0.168), but mean cortisol 1
was higher in women (mean 396.38nmol/L; limits 266–
536nmol/L, CI95% 360.16–432.61nmol/L) than in men
(mean 298.27nmol/L, limits 172–537nmol/L, CI95%
257.14–339.4nmol/L) with about 100nmol/L. t-test to
compare mean values identiﬁed a high statistical signiﬁcance
for the diﬀerence between the two areas (P = 0.0012).
Cortisol 2 values were measured in the evening, between
6 and 8 PM. An average value of 205.58nmol/L (limits 67–
327nmol/L; CI95% 186.27–224.88nmol/L) was identiﬁed in
all the subjects in group 1. Measurements in the evening re-
corded no signiﬁcant variation regarding age groups in
the healthy eldery (P = 0.09), but mean cortisol 2
was higher in women (mean 238.81nmol/L, limits 144–
317nmol/L, CI95% 217.27–260.34nmol/L) than in men
(mean183.97nmol/L,limits67–327nmol/L,CI95%156.76–
211.19nmol/L), with high statistical signiﬁcance for the
diﬀerence between the two areas (P = 0.0047).
Subset 2 consisted of elderly patients with hypertension
and cardiovascular disease, but not endocrine issues. These
patients were admitted for previously diagnosed cardiovas-
cular issues or newly diagnosed disease. Following the anam-
nesis, physical examination, and laboratory ﬁndings, a total
of 69 patients were selected for the study. Similar to subset 1,
subset 2 was composed of elderly over 65 years of age (ages
ranging from 65 to 90 years); the patients were also divided
into three age groups the same as group 1. Men were at a
slight advantage (40 cases—58%) over women (29 cases—
42%), sex ratio equaling 1.38 in the studied group. Women
taken into study from this group had ages between 65 and
89 years of age (mean age 77.69); the men had ages ranging
from 65 to 90 years old (mean age 78.22).
Meancortisol1measuredat8am,insubjectsincludedin
group 2, was 392.93nmol/L (limits 172–536nmol/L, CI95%
363.66–422.19nmol/L), while average cortisol 2 measured at
8 PM, among the cases in group 2, was 228.55nmol/L (limits
73–326nmol/L, CI95% 210.58–246.52nmol/L). There was
no statisticallysigniﬁcantlink between theageof thesubjects
o fs u b s e t2a n dc o r t i s o lv a l u e s1o r2 .
Knowing that, in the elderly multiple pathology is very
frequent; it was quite diﬃcult to select patients with one
cardiovascular disease. Thus, we have selected for the study
the most frequently encountered heart diseases in clinical
practice: high blood pressure (59%), ischemic heart disease
(58%), heart failure (29%), and ﬁbrillation (28%). The
associations between the above-mentioned issues are as fol-
lows:ﬁrstpairingwasrepresentedbyhypertension—ischem-
icheartdisease (17 cases,24.6%), followed bytheassociation
ofhypertension-heartfailure(11cases,15.9%),hypertension
and atrial ﬁbrillation (5 cases, 7.2%), and ﬁnally hyper-
tension, ischemic heart disease, heart failure, and atrial
ﬁbrillation (3 cases, 4.3%).
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Figure 1: Mean cortisol 1 in subset 1 and 2  by age groups.
For these reasons we have formed a group of patients
called subset 2 , with cardiovascular issues, but with clinical
dominating hypertension symptoms, consisting of 41 sub-
jects.
3.1. A Comparative Analysis of Cortisol 1 in the Two Groups.
Mean cortisol 1, measured within the hypertension domi-
nant group (subset 2 ), was 483.73nmol/L (limits 321–
536nmol/L, CI95% 471.46–496.01nmol/L).
Comparing the mean morning cortisol in the control
group(336.92nmol/L)tothatobtainedinpatientsfromsub-
set2 ,wenoticedthattheaveragevalueishigherforthelatter
(483.73nmol/L); the diﬀerence between the two values being
highly signiﬁcant in statistical terms (P<0.001) (Table 1).
By groups of age, mean cortisol 1 values were over
130nmol/L higher in hypertensive subjects compared with
the subjects in group 1, regardless of age pairings. A mean
cortisol 1 was averaging at about 480nmol/L in group 2 ,
while the subjects in group 1 did not record a value higher
than 346nmol/L (Figure 1).
Regardless of the grading of the hypertensive disease, pa-
tients with hypertension in group 2  had an average value of
cortisol 1 higher than the one recorded in the control group.
Also, as the severity of the hypertensive disease was great-
er, mean cortisol 1 was higher, the diﬀerence being highly
signiﬁcant (P<0.001). Thus, the subjects in subset 1 had a
mean cortisol 1 of 336.92nmol/L, while patients’ cortisol 1
value (from subset 2 ) increased proportional to the grading
of the hypertensive disease (grade 1—450nmol/L, grade 2—
482.31nmol/L, and grade—522.17nmol/L) (Figure 2).
3.2. A Comparative Analysis of Cortisol 2 in the Two Groups.
Cortisol 2 measured at 8 PM averaged at 205.58nmol/L in
subset1(limits67–327nmol/L; CI95%186.27–224.88nmol/
L). In subset 2, the average value of cortisol measured at
8 PM was higher—228.55nmol/L (limits 73–326nmol/L;
CI95% 210.58–246.52nmol/L). The diﬀerence between the
2 obtained values was not signiﬁcant in statistical terms.
Comparing the average value of cortisol 2 in subset 1
(205.58nmol/L) with the one obtained from the subjects
of subset 2 , we can clearly observe that the average value
in hypertensive patients (281.42nmol/L) is higher than4 International Journal of Hypertension
Table 1: Mean cortisol 1 in patients from subset 1 and 2 .
Cortisol 1 N Average CI95% SD Minimum Maximum P
Subset 1 66 336.92 306.47–367.38 123.89 172 537 <0.001
Subset 2  41 483.73 471.46–496.01 38.89 321 536
336.92
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Figure 2: Mean cortisol 1 value in subset 1 and in hypertensive
subjects.
289.85 278.56 275.6
211.43 200.77 205.68
150
200
250
300
350
400
450
500
550
C
o
r
t
i
s
o
l
 
2
 
(
n
m
o
l
/
L
)
>84
Subset 2
Subset 1
65–74 75–84
Figure 3: Mean cortisol 2 in patients from subsets 1 and 2  by age
groups.
the average value of cortisol 2 in the control group, this being
highly signiﬁcant (P<0.001) (Table 2).
If we analyse by age group, mean values of cortisol 2
(measured in the evening) were about 70nmol/L higher in
group 2  compared to the subjects of the control group in all
age groups (Figure 3).
Regardless of the grade of the hypertensive disease, mean
cortisol 2 values were higher than in group 1, and the more
severe the hypertension was, the higher the mean value of
cortisol2was.Thediﬀerencerecordedtothecontrolgroupis
highly signiﬁcant in statistical terms (P<0.001) (Figure 4).
3.3. A Comparative Analysis of Cortisol 1 and 2 Values in
the 2 Study Groups. For group 1 the mean cortisol 1 value
was 336.92nmol/L, and for cortisol 2 a mean value of
205.58nmol/L was identiﬁed. We can clearly say that in
control group subjects, for all age groups, mean cortisol 2
values were about 130nmol/L lower than those recorded
during the mornings (Figure 5).
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Figure 4: Mean cortisol 2 in subset 1 and 2  by grade of
hypertension.
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Figure 5: Dynamics of cortisol values in group 1.
Mean morning cortisol measured in subjects enrolled in
group 2 was 392.93nmol/L, and mean cortisol value meas-
ured at 8 PM in the same group was 228.55nmol/L. Just like
in the case of the control group, we can clearly state that the
patients with cardiovascular issues, in all age groups, have
mean values of cortisol 2 lower than the morning value with
over 150nmol/L (Figure 6).
Patients in group 2 had a more pronounced decrease in
cortisol 2 values than in cortisol 1 (over 150nmol/L), com-
pared with the decrease recorded in the control group (about
130nmol/L).
The patients in group 2 recorded a mean cortisol 1 value
higher (392.93nmol/L) than the one of the control group
(336.92nmol/L), the diﬀerence between the two values being
statistically signiﬁcant (P = 0.009).
Although average values of cortisol 2 were higher in
patients with cardiovascular disease (228.55nmol/L) com-
pared with the values obtained in the control group
(205.58nmol/L), the diﬀerence was not signiﬁcant in statis-
tical terms.International Journal of Hypertension 5
Table 2: Mean cortisol 2 in patients from subset 1 and 2 .
Cortisol 2 N Average CI95% SD Minimum Maximum P
Subset 1 66 205.58 186.27–224.88 78.54 67 327 <0.001
Subset 2  41 281.42 270.76–292.07 33.74 194 326
386.17 399.79 390.35
233.39 228.79 221.59
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Figure 6: Dynamics of cortisol values in group 2.
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Figure 7: Dynamics of cortisol values in hypertensive patients.
Forgroup2  (cardiovascularaﬄictedpatients,withdom-
inating hypertension symptoms), mean morning cortisol
was 483.73nmol/L and the evening cortisol in the same
patients was 281.42nmol/L. In hypertensive patients, mean
cortisol 1 values, by age groups, were similar, ranging be-
tween 481 and 486nmol/L, to cortisol 2 values which ranged
between 275 and 289nmol/L (Figure 7).
Decrease in cortisol 2 values in patients with hyperten-
sion was around 200nmol/L to morning cortisol in all age
groups. Comparing, the biggest diﬀerence between values of
cortisol 1 and 2, in patients in group 2 , was recorded in the
age groups of 75 to 84 and over 84 years (42.7% and 42.8%)
(Figure 8).
4. Discussion
The present study conﬁrms some existing data in the liter-
ature, namely that, in the elderly, normal levels of cortisol
are recorded. Because of purely economic reasons, multiple
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Figure 8: Percentage decrease in cortisol levels, by age groups, in
group 2 .
measurements of cortisol levels could not be performed in
the same patient.
In some studies, normal values of cortisol in elder pa-
tients have been recorded, but with a decrease in the ampli-
tude of its diurnal variations [10]; slightly elevated values
have also been recorded [11], especially in men with cardio-
vascular diseases [12], resistance to cortisol suppression also
being noticed in other studies [13].
In this study, the dynamics of cortisol was within nor-
malreferencelimits,bothinhealthyelderlyandinelderlyhy-
pertensive patients, with occasional narrowing or widening
of the range of obtained results.
We noted that healthy women over 65 years in group 1
had higher mean cortisol levels than average elderly men
from the same set.
Elderly hypertensive patients had mean cortisol values
greater than those obtained in healthy people aged over
65 years. It is highly important that the mean values of
cortisol, regardless of when they were determined (morning
orevening),variedalongwiththeseverityofbloodhyperten-
sion: the higher the degree of hypertension was, the higher
the mean cortisol value was.
Patients with cardiovascular disease, especially hyperten-
sivepatients,showedamorepronounceddecreaseofevening
determined cortisol values, compared with healthy elderly.
5. Conclusion
(1) Mean morning and evening cortisol measured in
both groups were within normal limits, approaching
the upper limit of reference.
(2) Mean morning and evening cortisol determined were
higher in healthy women compared with men from
the same group.6 International Journal of Hypertension
(3) The mean values of morning and evening cortisol
recorded in hypertensive patients were higher than
the values obtained from healthy patients.
(4) The severity of blood hypertension correlated with
cortisol values: the higher the grading of hyperten-
sionwas,thehighermeancortisoldeterminedduring
morning or evening was.
(5) We take into account the need to introduce the
screeningofhormonallevels(speciﬁcallycortisolval-
ues) in elderly patients, because the modiﬁed values
of certain hormones may become predictive factors
fortheevolutionandprognosisofcardiovasculardis-
eases.
References
[ 1 ]H .B .M e r c ka n dR .B e r k o w ,The Merck Manual of Geriatrics,
Merck, Whitehouse Station, NJ, USA, 3rd edition, 2000.
[2] R. Ladisls, “Cellular and molecular mechanisms of aging and
age related diseases,” Pathology and Oncology Research, vol. 6,
no. 1, pp. 3–9, 2000.
[3] T. M. Buckley and A. F. Schatzberg, “Aging and the role of the
HPA axis and rhythm in sleep and memory-consolidation,”
American Journal of Geriatric Psychiatry,v o l .1 3 ,n o .5 ,p p .
344–352, 2005.
[4] B. Baranowska, E. Wolinska-Witort, W. Bik, A. Baranowska-
Bik, L. Martynska, and M. Chmielowska, “Evaluation of neu-
roendocrinestatusinlongevity,”NeurobiologyofAging,vol.28,
no. 5, pp. 774–783, 2007.
[5] R. G. Smith, L. Betancourt, and Y. Sun, “Molecular endocri-
nology and physiology of the aging central nervous system,”
Endocrine Reviews, vol. 26, no. 2, pp. 203–250, 2005.
[6] K. L. Becker, “Endocrinology and aging,” in Principles and
Practice of Endocrinology & Metabolism, chapter 199, Lippin-
cott Williams & Wilkins, Philadelphia, Pa, USA, 2002.
[7] D. F. Kripke, S. D. Youngstedt, J. A. Elliott et al., “Circadian
phase in adults of contrasting ages,” Chronobiology Interna-
tional, vol. 22, no. 4, pp. 695–709, 2005.
[ 8 ] E .v a nC a u t e r ,R .L e p r o u l t ,a n dD .J .K u p f e r ,“ E ﬀects of gender
and age on the levels and circadian rhythmicity of plasma
cortisol,” Journal of Clinical Endocrinology and Metabolism,
vol. 81, no. 7, pp. 2468–2473, 1996.
[9] A. N. Vgontzas, M. Zoumakis, E. O. Bixler et al., “Impaired
nighttime sleep in healthy old versus young adults is asso-
ciated with elevated plasma interleukin-6 and cortisol levels:
physiologic and therapeutic implications,” Journal of Clinical
Endocrinology and Metabolism, vol. 88, no. 5, pp. 2087–2095,
2003.
[10] G. Valenti, “Adrenopause: an imbalance between dehydroe-
piandrosterone (DHEA) and cortisol secretion,” Journal of
Endocrinological Investigation, vol. 25, no. 10, pp. 29–35, 2002.
[11] O. Chehab, M. Ouertani, K. Chaieb, F. Haouala, and K. Mah-
douani, “Hormonal status of cortisol and dehydroepiandros-
terone sulfate in an elderly Tunisian population,” Comptes
Rendus Biologies, vol. 330, no. 10, pp. 755–763, 2007.
[12] Z.Y .Zhao ,F .H.L u,Y .Xie,Y .R.F u,A.Bogdan,andY .T ouitou,
“Cortisol secretion in the elderly. Inﬂuence of age, sex and
cardiovascular disease in a Chinese population,” Steroids, vol.
68, no. 6, pp. 551–555, 2003.
[13] N. Carvalhaes-Neto, M. K. Huayllas, L. R. Ramos, M. S. Cen-
doroglo, and C. E. Kater, “Cortisol, DHEAS and aging: resist-
ance to cortisol suppression in frail institutionalized elderly,”
Journal of Endocrinological Investigation, vol. 26, no. 1, pp. 17–
22, 2003.